查看购物车
  • Traditional Chinese
  • English
2021-2031 年北美医学写作市场报告（范围、细分、动态和竞争分析）
市场调查报告书
商品编码
1819735

2021-2031 年北美医学写作市场报告（范围、细分、动态和竞争分析）

North America Medical Writing Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 175 Pages | 订单完成后即时交付

价格

北美医学写作市场预计将大幅成长，到 2031 年将达到 31.2866 亿美元，高于 2023 年的 13.3339 亿美元。这一成长代表着 2023 年至 2031 年的年复合成长率(CAGR) 为 11.3%。

执行摘要和市场分析

北美医学写作行业的发展主要受多种因素驱动，包括监管要求的不断提高、临床试验数量的增加以及製药和生物技术行业的扩张。美国食品药物管理局 (US FDA) 等监管机构制定的严格合规标准进一步推动了对精准医疗文件的需求。此外，医学写作任务外包的趋势也促进了市场的成长。

市场区隔分析

北美医学写作市场可以根据类型、应用和最终用户进行细分。

1. 依类型：市场分为临床写作、法规写作和科学写作。 2023年，临床写作占据了最大的市场份额，反映了其在临床试验和法规提交文件中的关键作用。

2. 按应用：医学写作的应用包括医学新闻、医学教育和医学行销。医学新闻是2023年的领先领域，凸显了准确且引人入胜的沟通在医学领域的重要性。

3. 依最终用户划分：市场分为製药和生物技术公司以及合约研究组织 (CRO)。 2023 年，製药和生物技术公司占据了更大的市场份额，这得益于它们在整个药物开发过程中对全面文件记录的需求。

市场展望

监管机构要求详细记录产品开发各阶段所使用的方法，以批准生物製药和製药业的新产品。保险公司也要求提供详尽的药品信息，以便制定报销政策。这对製药和生物製药公司遵守行业标准提出了重大挑战。

医学撰稿人在这过程中发挥着至关重要的作用，因为他们参与了各种任务，为方案设计提供洞见。临床试验产生的资料必须准确地反映在产品标籤中，并以简单易懂的方式进行总结，避免使用专业术语。医学撰稿人擅长根据监管要求处理和分析讯息，这有助于加快文件开发流程，从而缩短整个药物开发週期。这种效率对于顺利获得监管部门的批准至关重要，因此医学写作在业界的重要性日益凸显。

国家洞察

北美医学写作市场包括美国、加拿大和墨西哥，其中美国在 2023 年占据最大市场份额。

美国医学写作市场的成长受到以下几个关键因素的推动：

  • 监管需求：药品审批数量激增，包括2023年美国药品审查与研究中心 (CDER) 批准的55种新药，这增加了对准确监管文件的需求。医学撰稿人在准备临床研究报告、监管提交文件和其他合规文件方面至关重要。
  • 临床试验成长：美国是临床试验的领先中心，尤其是在肿瘤学、罕见疾病和免疫学等领域。临床试验数量的不断增加，需要医学撰稿人为试验方案、监管备案和临床报告提供支援。
  • 製药和生物技术扩张：辉瑞、强生和默克等大型製药公司在美国的存在推动了对监管提交、临床试验报告和产品标籤的需求，进一步扩大了医学写作市场。

市场关键参与者

北美医学写作市场的知名企业包括IQVIA、Parexel、Syneos Health和Covance。这些公司正在采用各种市场扩张策略，包括建立合作伙伴关係和合作。例如，Parexel已与人工智慧系统领域的领导者Palantir Technologies Inc.建立策略联盟，以提升生物製药客户临床试验的效率和安全性。此次合作旨在利用Palantir的技术改善Parexel的临床资料平台，从而简化临床试验流程，同时维持高标准的安全性和合规性。

公司简介

北美医学写作市场的主要公司包括 Cactus Communications、Parexel International Corp、Certara Inc.、Freyr LLC、Quanticate International Ltd、SIRO Clinpharm Pvt Ltd、ProPharma Group、Caidya、Wipro Ltd、SGS SA、Laboratory Corp of America Holdings、TUNECT、Indegene Ltd、Evidera、SGS- SA、Laboratory CorpTu-G Holdings、TUNECT、Indegene Ltd、Evidera、SEM-G」表、Ovptics Biovplate、Tirii、Trapal​​namp、Evidera、SEM-Gated Consultancy Services Ltd、InClin 和 TransPerfect Life Sciences。这些公司正在采取各种策略，例如扩张、产品创新和併购，以增强其产品组合併提高市场份额。

目录

第一章：简介

第二章：执行摘要

  • 关键见解

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第四章：北美医学写作市场格局

  • 概述
  • PEST分析

第五章：北美医学写作市场－关键市场动态

  • 市场驱动因素
    • 医学写作对于获得监管机构批准的重要性日益凸显
    • 高度青睐CRO
  • 市场限制
    • 缺乏熟练的医学作家
  • 市场机会
    • 对监管和临床试验文件的需求不断增加
  • 未来趋势
    • 医学写作中的工具和人工智慧的实施
  • 驱动因素和限制因素的影响：

第六章：医学写作市场－北美市场分析

  • 2021-2031年北美医学写作市场收入
  • 北美医学写作市场预测分析

第七章：北美医学写作市场分析－按类型

  • 临床写作
  • 监管文件撰写
  • 科学写作
  • 其他的

第 8 章：北美医学写作市场分析 - 按应用

  • 医学新闻学
  • 医学教育
  • 医疗行销
  • 其他的

第九章：北美医学写作市场分析－按最终用户

  • 製药和生物技术公司
  • 合约研究组织

第 10 章：北美医学写作市场 - 国家分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

第 11 章：产业格局

  • 概述
  • 医学写作市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第十二章：公司简介

  • Cactus Communications
  • Parexel International Corp
  • Certara Inc.
  • Freyr LLC
  • Quanticate International Ltd
  • SIRO Clinpharm Pvt Ltd
  • ProPharma Group
  • Caidya
  • Wipro Ltd
  • SGS SA
  • Laboratory Corp of America Holdings
  • TUNECT
  • Indegene Ltd
  • Evidera
  • Syner-G BioPharma Group
  • EMTEX BV
  • BioAgile Therapeutics Private Limited
  • Tata Consultancy Services Ltd
  • InClin
  • TransPerfect Life Sciences

第 13 章：附录

Product Code: TIPRE00016267

The North American medical writing market is projected to grow significantly, reaching an estimated US$ 3,128.66 million by 2031, up from US$ 1,333.39 million in 2023. This growth represents a compound annual growth rate (CAGR) of 11.3% from 2023 to 2031.

Executive Summary and Market Analysis

The medical writing sector in North America is primarily driven by several factors, including increasing regulatory requirements, a rise in the number of clinical trials, and the expansion of the pharmaceutical and biotechnology industries. The demand for precise medical documentation is further fueled by stringent compliance standards set by regulatory bodies such as the United States Food and Drug Administration (US FDA). Additionally, the trend of outsourcing medical writing tasks is contributing to the market's growth.

Market Segmentation Analysis

The North American medical writing market can be segmented based on type, application, and end user.

1. By Type: The market is divided into clinical writing, regulatory writing, and scientific writing. In 2023, clinical writing held the largest market share, reflecting its critical role in the documentation of clinical trials and regulatory submissions.

2. By Application: The applications of medical writing include medical journalism, medical education, and medico marketing. Medical journalism was the leading segment in 2023, highlighting the importance of accurate and engaging communication in the medical field.

3. By End User: The market is categorized into pharmaceutical and biotechnology companies and contract research organizations (CROs). In 2023, pharmaceutical and biotechnology companies accounted for a larger share of the market, driven by their need for comprehensive documentation throughout the drug development process.

Market Outlook

Regulatory authorities require detailed documentation of methodologies used during all phases of product development to approve new products in the biopharmaceutical and pharmaceutical sectors. Insurance providers also demand thorough information about drugs to establish reimbursement policies. This creates a significant challenge for pharmaceutical and biopharmaceutical companies to adhere to industry standards.

Medical writers play a vital role in this process, as they are involved in various tasks that provide insights into protocol design. The data generated from clinical trials must be accurately reflected in product labeling and summarized in a way that is understandable, avoiding technical jargon. Medical writers are adept at processing and analyzing information according to regulatory requirements, which helps expedite the document development process and, consequently, the overall drug development timeline. This efficiency is crucial for obtaining regulatory approvals smoothly, thereby increasing the importance of medical writing in the industry.

Country Insights

The North American medical writing market includes the United States, Canada, and Mexico, with the US holding the largest market share in 2023.

The growth of the US medical writing market is driven by several key factors:

  • Regulatory Demands: The surge in drug approvals, including 55 new drugs approved by the Center for Drug Evaluation and Research (CDER) in 2023, has increased the need for accurate regulatory documentation. Medical writers are essential in preparing clinical study reports, regulatory submissions, and other compliance documents.
  • Clinical Trials Growth: The US is a leading hub for clinical trials, particularly in areas such as oncology, rare diseases, and immunology. The increasing number of clinical trials necessitates the support of medical writers for trial protocols, regulatory filings, and clinical reports.
  • Pharmaceutical and Biotech Expansion: The presence of major pharmaceutical companies like Pfizer, Johnson & Johnson, and Merck in the US drives the demand for regulatory submissions, clinical trial reports, and product labeling, further expanding the medical writing market.

Key Players in the Market

Prominent players in the North American medical writing market include IQVIA, Parexel, Syneos Health, and Covance. These companies are employing various strategies for market expansion, including partnerships and collaborations. For instance, Parexel has formed a strategic alliance with Palantir Technologies Inc., a leader in artificial intelligence systems, to enhance the efficiency and safety of clinical trials for biopharmaceutical clients. This collaboration aims to leverage Palantir's technology to improve Parexel's clinical data platform, thereby streamlining the clinical trial process while maintaining high standards of safety and regulatory compliance.

Company Profiles

Key companies operating in the North American medical writing market include Cactus Communications, Parexel International Corp, Certara Inc., Freyr LLC, Quanticate International Ltd, SIRO Clinpharm Pvt Ltd, ProPharma Group, Caidya, Wipro Ltd, SGS SA, Laboratory Corp of America Holdings, TUNECT, Indegene Ltd, Evidera, Syner-G BioPharma Group, EMTEX BV, BioAgile Therapeutics Private Limited, Tata Consultancy Services Ltd, InClin, and TransPerfect Life Sciences. These companies are pursuing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase their market share.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:

4. North America Medical Writing Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. North America Medical Writing Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Importance of Medical Writing to Obtain Approval from Regulatory Authorities
    • 5.1.2 High Preference for CROs
  • 5.2 Market Restraints
    • 5.2.1 Insufficient Skilled Medical Writers
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Demand for Regulatory and Clinical Trial Documentation
  • 5.4 Future Trends
    • 5.4.1 Implementation of Tools and Artificial Intelligence in Medical Writing
  • 5.5 Impact of Drivers and Restraints:

6. Medical Writing Market - North America Market Analysis

  • 6.1 North America Medical Writing Market Revenue (US$ Million), 2021-2031
  • 6.2 North America Medical Writing Market Forecast Analysis

7. North America Medical Writing Market Analysis - by Type

  • 7.1 Clinical Writing
    • 7.1.1 Overview
    • 7.1.2 Clinical Writing: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Regulatory Writing
    • 7.2.1 Overview
    • 7.2.2 Regulatory Writing: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Scientific Writing
    • 7.3.1 Overview
    • 7.3.2 Scientific Writing: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Medical Writing Market Analysis - by Application

  • 8.1 Medical Journalism
    • 8.1.1 Overview
    • 8.1.2 Medical Journalism: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Medical Education
    • 8.2.1 Overview
    • 8.2.2 Medical Education: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Medico Marketing
    • 8.3.1 Overview
    • 8.3.2 Medico Marketing: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Medical Writing Market Analysis - by End User

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Overview
    • 9.1.2 Pharmaceutical and Biotechnology Companies: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Contract Research Organizations
    • 9.2.1 Overview
    • 9.2.2 Contract Research Organizations: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Medical Writing Market - Country Analysis

  • 10.1 North America
    • 10.1.1 North America Medical Writing Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 North America Medical Writing Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 United States: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.2.1 United States: North America Medical Writing Market Share - by Type
        • 10.1.1.2.2 United States: North America Medical Writing Market Share - by Application
        • 10.1.1.2.3 United States: North America Medical Writing Market Share - by End User
      • 10.1.1.3 Canada: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.3.1 Canada: North America Medical Writing Market Share - by Type
        • 10.1.1.3.2 Canada: North America Medical Writing Market Share - by Application
        • 10.1.1.3.3 Canada: North America Medical Writing Market Share - by End User
      • 10.1.1.4 Mexico: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.4.1 Mexico: North America Medical Writing Market Share - by Type
        • 10.1.1.4.2 Mexico: North America Medical Writing Market Share - by Application
        • 10.1.1.4.3 Mexico: North America Medical Writing Market Share - by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Medical Writing Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Cactus Communications
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Parexel International Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Certara Inc.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Freyr LLC
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Quanticate International Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Financial Overview
    • 12.5.4 SWOT Analysis
    • 12.5.5 Key Developments
  • 12.6 SIRO Clinpharm Pvt Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 ProPharma Group
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Caidya
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Wipro Ltd
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 SGS SA
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Laboratory Corp of America Holdings
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 TUNECT
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 Indegene Ltd
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments
  • 12.14 Evidera
    • 12.14.1 Key Facts
    • 12.14.2 Business Description
    • 12.14.3 Products and Services
    • 12.14.4 Financial Overview
    • 12.14.5 SWOT Analysis
    • 12.14.6 Key Developments
  • 12.15 Syner-G BioPharma Group
    • 12.15.1 Key Facts
    • 12.15.2 Business Description
    • 12.15.3 Financial Overview
    • 12.15.4 SWOT Analysis
    • 12.15.5 Key Developments
  • 12.16 EMTEX BV
    • 12.16.1 Key Facts
    • 12.16.2 Business Description
    • 12.16.3 Products and Services
    • 12.16.4 Financial Overview
    • 12.16.5 SWOT Analysis
    • 12.16.6 Key Developments
  • 12.17 BioAgile Therapeutics Private Limited
    • 12.17.1 Key Facts
    • 12.17.2 Business Description
    • 12.17.3 Products and Services
    • 12.17.4 Financial Overview
    • 12.17.5 SWOT Analysis
    • 12.17.6 Key Developments
  • 12.18 Tata Consultancy Services Ltd
    • 12.18.1 Key Facts
    • 12.18.2 Business Description
    • 12.18.3 Products and Services
    • 12.18.4 Financial Overview
    • 12.18.5 SWOT Analysis
    • 12.18.6 Key Developments
  • 12.19 InClin
    • 12.19.1 Key Facts
    • 12.19.2 Business Description
    • 12.19.3 Products and Services
    • 12.19.4 Financial Overview
    • 12.19.5 SWOT Analysis
    • 12.19.6 Key Developments
  • 12.20 TransPerfect Life Sciences
    • 12.20.1 Key Facts
    • 12.20.2 Business Description
    • 12.20.3 Products and Services
    • 12.20.4 Financial Overview
    • 12.20.5 SWOT Analysis
    • 12.20.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms for Medical Writing Market

List Of Tables

  • Table 1. North America Medical Writing Market Segmentation
  • Table 2. North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
  • Table 4. North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 5. North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
  • Table 6. North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 7. United States: North America Medical Writing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 8. United States: North America Medical Writing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 9. United States: North America Medical Writing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 10. Canada: North America Medical Writing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 11. Canada: North America Medical Writing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 12. Canada: North America Medical Writing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 13. Mexico: North America Medical Writing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 14. Mexico: North America Medical Writing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 15. Mexico: North America Medical Writing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 16. Recent Organic Growth Strategies in Medical Writing Market
  • Table 17. Recent Inorganic Growth Strategies in the Medical Writing Market
  • Table 18. Glossary of Terms

List Of Figures

  • Figure 1. North America Medical Writing Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. North America Medical Writing Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Medical Writing Market Revenue (US$ Million), 2021-2031
  • Figure 6. North America Medical Writing Market Share (%) - by Type (2023 and 2031)
  • Figure 7. Clinical Writing: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Regulatory Writing: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Scientific Writing: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Others: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. North America Medical Writing Market Share (%) - by Application (2023 and 2031)
  • Figure 12. Medical Journalism: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Medical Education: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Medico Marketing: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Others: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. North America Medical Writing Market Share (%) - by End User (2023 and 2031)
  • Figure 17. Pharmaceutical and Biotechnology Companies: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Contract Research Organizations: North America Medical Writing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. North America Medical Writing Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 20. United States: North America Medical Writing Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 21. Canada: North America Medical Writing Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 22. Mexico: North America Medical Writing Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 23. Growth Strategies in Medical Writing Market